Dermazentrum Augsburg

Augsburg, Bavaria 86179

0 studies enrolling now · 2 studies all time

What they study most

Atopic Dermatitis, Psoriasis

Studies at this site

• Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin) — Completed
• A Study to Investigate Interchangeability of ABP 654 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis — Completed